This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,749.20 contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The order has an ultimate completion date of December 3, 2024. Amerisourcebergen, a for-profit organization, is registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/9/25, 12:51 AM